Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Deoxycholic acid for Sale > Deoxycholic acid 99% white crystalline powder Renli
Deoxycholic acid 99% white crystalline powder  Renli buy - large image1
Deoxycholic acid 99% white crystalline powder  Renli buy - image1

Deoxycholic acid 99% white crystalline powder Renli

7 Inquiries

Unit Price: Get Latest Price
CAS No.:

83-44-3

Grade:

Pharmaceutical Grade

Content:

99%

Brand:

Renli

Packaging:

25kg/ drum

Price valid (until):

2023-03-10

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Information about Deoxycholic acid
     

    ItemsResults
    Molecula FomulaC24H40O4
    CAS 83-44-3
    Appearancewhite crystalline powder
    Assay≥ 99%
    Deoxycholic acid is a bile acid lacking hydroxyl group on C-7. It is a free bile
    acid derived from the loss of an oxygen atom of cholic acid. It mainly exists
    in the form of taurine and glycine in bile. It can be used in the areas of  biochemical research;
    Bacteriological and enzymatic studies; Lipase accelerator; Anion remover for protein dissolution;

    About us

    Xieli Pharm was Founded in 1980's With cGMP\ EU GMP\ Japan GMP certified factory and independent R&D center.
    Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP, CEP for Diosmin and Troxerutin
    OEM for plant extracting and TCM Processing CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.

    Chengdu Renli Biotechnology Co., Ltd (hereinafter refer to Renli) is a wholly- owned subsidiary of Sichuan 
    Xieli Pharmaceuticals Co., Ltd, which mainly focused on the production of intermediates. The products of
    Renli include Berberine HCL, natural indigo, rutin, quercetin, rhamnose, baicalin, 10-Hydroxy- CPT ,
    cholic acid, bilirubin,deoxycholic acid.

    Basic Info
    Product Name:

    Deoxycholic acid

    Other Name:

    Cholan-24-oic acid,3,12-dihydroxy-,(3α,5β,12α)-;5β-Cholan-24-oic acid,3α,12α-dihydroxy-;(3α,5β,12α)-3,12-Dihydroxycholan-24-oic acid;Cholic acid,deoxy-;Cholorebic;Degalol;Deoxycholatic acid;Deoxycholic acid;Desoxycholic acid;3α,12α-Dihydroxycholanic acid;3α,12α-Dihydroxy-5β-cholanoic acid;Droxolan;17β-[1-Methyl-3-carboxypropyl]-etiocholane-3α,12α-diol;3α,12α-Dihydroxy-5β-cholanic acid;Cholerebic;Pyrochol;Septochol;3α,12α-Dihydroxy-5β-cholan-24-oic acid;5β-Deoxycholic acid;5β-Cholanic acid-3α,12α-diol;7-Deoxycholic acid;NSC 8797;ATX 101;Kybella;728917-93-9

    CAS No.:

    83-44-3

    Molecular Formula:

    C24H40O4

    InChIKeys:

    InChIKey=KXGVEGMKQFWNSR-LLQZFEROSA-N

    Molecular Weight:

    392.57

    Exact Mass:

    392.57

    BRN:

    3219882

    EC Number:

    201-478-5

    UNII:

    005990WHZZ

    NSC Number:

    8797

    DSSTox ID:

    DTXSID0042662

    Color/Form:

    CRYSTALS FROM ALC

    ATC Code:

    D - Dermatologicals

    HScode:

    29181990

    Characteristics
    PSA:

    77.8

    XLogP3:

    4.9

    Appearance:

    Solid

    Density:

    1.1±0.1 g/cm3

    Melting Point:

    176-178 °C

    Boiling Point:

    547.1ºC at 760 mmHg

    Flash Point:

    9℃

    Refractive Index:

    1.543

    Water Solubility:

    H2O: 0.24 g/L (15 ºC)

    Storage Conditions:

    Store at RT.

    Toxicity:

    LD50 oral in rat: 1gm/kg

    Specific rotation:

    55 º (c=1, EtOH)

    Dissociation Constants:

    pK= 6.58

    Collision Cross Section:

    200.7 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|209.86 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|202.2 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|202.3 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|196.7 Ų [M+Na]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|202.1 Ų [M-H]-

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 3

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    H412 Harmful to aquatic life with long lasting effects

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    P273 Avoid release to the environment.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

    Location:

    NO.588, middle section of mudan avenue

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    15

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    501-1000

    Year of Establishment:

    1992

    Company Profile
    Xieli Pharm was founded in 1980's with cGMP\ EU GMP\ Japan GMP certified factory and independent R&D center. Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP; CEP for Diosmin and Troxerutin OEM for plant extracting and TCM Processing CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.
  • Inquiry History
    7 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    High Quality Pharmaceutical Grade CAS 83-44-3 Deoxycholic Acid

    50 KG Sep 1, 2023
    Brazil

    Deoxycholic Acid

    1 MT May 20, 2024
    United States

    Deoxycholic acid

    1 G May 15, 2026
    Israel

    Deoxycholic acid

    100 G Sep 3, 2025
    United States

    Deoxycholic acid

    10 MT May 30, 2026
    United Kingdom

    deoxycholic acid

    100 G Oct 28, 2024
    United States

    deoxycholic acid

    May 4, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.